Webinar | What Happens Now with Cannabis Rescheduling?

Webinar | What Happens Now with Cannabis Rescheduling?

Industry Leaders on Medical Marijuana in Schedule III,

June 29 Hearing and Expected Litigation

As the efforts to reschedule cannabis continue, many questions and misconceptions continue to surround the industry because DOJ’s announcement doesn’t automatically reschedule cannabis; it is only the beginning of a complex legal and regulatory process that will unfold over months, involving rulemaking, a public comment period and likely litigation.

Register to join Vicente LLP and the Marijuana Policy Project on Monday, April 27 at 11 AM MT / 1 PM ET for an industry leadership panel featuring cannabis attorneys, advocates and policy experts who have played key roles in this historic shift in federal drug policy.

They will discuss the rulemaking process, legal, regulatory, and business implications, and how rescheduling may affect the most pressing concerns of cannabis stakeholders.

• An immediate analysis of the reclassification order and the dismantling of the 1970 framework.

• How moving cannabis to Schedule III would impact state-legal programs and broader frameworks for hemp and cannabinoid programs

• Process around 280E applications and timeline

• DEA registration and compliance process for current medical cannabis businesses

• Predictions for the Administrative Hearing, including views from NORML’s Paul Armentano

• Impacts for state medical and future adult use states, featuring MPP’s Adam Smith

• Common misconceptions about cannabis rescheduling and its implications for employment law, M&A, litigation and taxation

• FDA guidance on health claims, labeling and drug development processes

• Anticipated litigation from prohibitionist groups and its potential impacts on the process